2025 Communication Pharmaceutical Companies 
Pharma Marketing Network
DECEMBER 4, 2024
As we approach 2025, emerging trends are reshaping how the industry engages with patients and healthcare providers. Companies are investing heavily in digital tools to streamline communication and build stronger connections. Patient-Centric Marketing Patients want to feel heard. Q2: What is patient-centric marketing in pharma?
Pharma Marketing Network
OCTOBER 17, 2024
In an increasingly competitive pharmaceutical landscape, the significance of healthcare branding has never been more pronounced. As we approach 2025, the ability of pharmaceutical companies to effectively craft and communicate their brand identity will play a pivotal role in determining their market success.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharma Marketing Network
OCTOBER 17, 2024
As we approach 2025, the pharmaceutical industry is witnessing a seismic shift in marketing strategies, driven by technological advancements and evolving consumer expectations. With the increasing digitization of healthcare, pharmaceutical companies are leveraging digital platforms to reach broader audiences more effectively.
Pharma Marketing Network
JANUARY 7, 2025
In 2025, pharma marketing news is filled with innovation, disruption, and opportunities to grow your business. Digital Dominance in Pharma Marketing The digital revolution has officially taken over the pharmaceutical industry, and theres no turning back. A significant focus for regulatory bodies has been on transparency.
Pharma Marketing Network
DECEMBER 17, 2021
The wave of interest in sustainability follows the value chain from top-tier pharmaceutical companies to their suppliers of every size. About 80% of pharmaceutical companies have announced a commitment to becoming carbon-neutral or made a net-zero pledge for carbon emissions. Health for Humanity 2025 Goals.
pharmaphorum
OCTOBER 13, 2022
However, patent protection remains in some major markets, including France, Italy, Spain, and the UK until 2025. The question is whether other major pharmaceutical companies will be attracted to the space – particularly when areas such as oncology and orphan drugs currently provide a larger return on investment.
pharmaphorum
JANUARY 10, 2023
Approximately 30% of global data volume is generated by the healthcare industry and it will continue to expand with a compound annual growth rate predicted to reach 36% by 2025, according to research by RBC Capital Markets. It flows from every direction in torrents to create huge opportunities to address the world’s mounting health issues.
Expert insights. Personalized for you.
52 
Let's personalize your content